November 2024

Volume 1, Issue 2

Table of Contents

Membership Corner

You've Got a Friend in Me: A Case for Cross-SIG Collaboration

Education Committee Updates

Deadline for Future ISPE Insights

Recap on ISPE Annual 2024

Do you want to be more involved with ISPE?

The Medications in Pregnancy and Lactation (MiPaL) SIG

Membership Corner

Daniela Moga, MD, PhD, FISPE

The ISPE Membership Committee hosted another successful “New Member and Early-Stage Career Luncheon” during the 40th ISPE Annual meeting in Berlin. Many thanks to everyone involved... Continue reading.

You've Got a Friend in Me: A Case for Cross-SIG Collaboration

Julien Heidt, Jie (Jenni) Li, Tara MacCannell, Daniel Rosenberg, Timothy Savage, Delphine Saragoussi

There are approximately 7,000 rare diseases which collectively impact more than 250 million people globally (US FDA, 2019) (Wakap et al., 2020). Approximately 80% of rare diseases are associated with a single gene mutation, and about half of these diseases affect children (Batshaw et al., 2014). Many of these rare diseases are life-threatening, and most have no approved disease-modifying therapies, representing substantial unmet medical need among pediatric patient populations. Recognizing this gap, researchers and manufacturers are making strides in the development of new therapies. Continue reading.

Education Committee Updates

Katsiaryna Bykov, PharmD, ScD

Get caught up on the web: did you know that you can access ISPE’s recorded meeting materials and webinars online at the ISPE Education Center? This past year, the Education Committee has held ten webinars, all of which are available through the website. Continue reading.

Deadline for future ISPE Insights

Taichi Ochi, PhD



With this second issue of ISPE Insights, we hope you have enjoyed the latest news from across the ISPE community. To keep the momentum going of sharing activities across ISPE, we are actively looking for content for future editions of ISPE Insights. As this newsletter was started to enhance communication and engagement across the global ISPE community, we strive to be a platform where latest community developments are shared. What kind of content are we looking for? Continue reading.

Recap on ISPE Annual 2024

Cheng (Alice) Chen

Looking back to Berlin

Two months have passed since ISPE Annual 2024. Over the course of six days, participants engaged in courses, presented their latest research and were able to join in the festivities of celebrating the 40th edition of ICPE. We hope you had a wonderful time at the conference! Continue reading.

Do you want to be more involved with ISPE?

Following ICPE 2024 in Berlin, the opportunity to join a Committee, Council, RIG and SIG was shared across the ISPE membership. Did you forget to register on time? Not to worry! There are still opportunities for you to be active within the ISPE community. Continue reading.

The Medications in Pregnancy and Lactation (MiPaL) SIG

Sandra Lopez-Leon, MD, PhD, FISPE

The Medications in Pregnancy and Lactation (MiPaL) SIG invites you to view our October 2024 newsletter. Feel free to share with others outside of ISPE/ the SIG, as you like. If you are interested in these topics, join our SIG: we would love to have you.

ISPE Annual Deadlines

As the end of the year approaches, ISPE would like to remind you the deadlines for ISPE Annual 2025 in Washington DC are fast approaching! The deadline for posters, oral presentations, workshops, and symposia abstracts is February 12, 2025.

More information pertaining to the newcomer track will be shared soon. The submission portal is not yet open but you will be notified when it is opened for both opportunities. 

Check out the ISPE Educational Resources

If you cannot wait until the next ISPE Annual courses or workshops, visit the ISPE educational resources page to see past webinars and other educational materials (here). One can also see archives of previous ISPE events.